Compare ADVB & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADVB | RVYL |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Medical Specialities | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 8.5M |
| IPO Year | N/A | 2008 |
| Metric | ADVB | RVYL |
|---|---|---|
| Price | $4.36 | $7.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 27.0K | 16.4K |
| Earning Date | 05-14-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,131,000.00 |
| Revenue This Year | N/A | $770.54 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.26 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.19 | $0.14 |
| 52 Week High | $7.70 | $8.55 |
| Indicator | ADVB | RVYL |
|---|---|---|
| Relative Strength Index (RSI) | 43.09 | 67.46 |
| Support Level | $3.73 | $5.00 |
| Resistance Level | $5.83 | $8.55 |
| Average True Range (ATR) | 0.54 | 0.65 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 15.77 | 96.06 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Ryvyl Inc is a financial technology company that provides payment acceptance and disbursement solutions, mainly enabling merchants to process credit card transactions through BIN sponsorship arrangements with acquiring banks and payment processors, where it operates as an intermediary performing functions such as merchant underwriting, onboarding, risk monitoring, and customer support. The company also offers its internally developed NEMS Core platform, which facilitates automated inbound and outbound disbursements through a modular workflow system.